Day: September 7, 2023

CARSON CITY, Nev., Sept. 07, 2023 (GLOBE NEWSWIRE) — BioVie Inc., (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease, is hosting today a virtual KOL event titled NE3107―Putting Data in Context, ahead of the upcoming Phase 3 results in Alzheimer’s Disease. The event will take place today at 2:30pm ET. To register, click here. The event will focus on BioVie’s lead product candidate, NE3107, currently in a potentially pivotal Phase 3 study in patients with mild to moderate Alzheimer’s disease with expected topline data readout in the fourth quarter of 2023. The company’s leadership team and Key Opinion Leader (KOL) Steven E. Arnold, MD (Harvard Medical School; Massachusetts General Hospital)...

NEW YORK, Sept. 07, 2023 (GLOBE NEWSWIRE) — BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a global clinical-stage biopharmaceutical company focused on using a groundbreaking technology platform for drug discovery and developing innovative therapies to improve clinical outcomes for patients with high unmet medical needs, today announced that management will present and participate in the R.W. Baird’s 2023 Global Healthcare Conference, taking place on September 12 to 13, 2023 in New York City. The presentation will be accessible on BeyondSpring’s website on the Events & Presentations page following the conclusion of the conference. About BeyondSpringBeyondSpring (NASDAQ: BYSI) is a global clinical-stage biopharmaceutical company focused on developing innovative therapies to improve clinical outcomes for...

Thumzup Media CorporationThe Thumzup mobile appPaid content creators have grown more than 786% this year Los Angeles, CA, Sept. 07, 2023 (GLOBE NEWSWIRE) — Thumzup Media Corporation (“Thumzup” or the “Company”) (OTCQB: TZUP) is pleased to announce that it has surpassed 10,000 paid posts on its platform*. The news comes on the heels of Thumzup recently announcing its userbase has grown by more than 786 percent this year. The Thumzup mobile app, which is available for download in the App Store and Google Play, enables advertisers to garner user generated content from customers and fans, incentivizing them to become social media advocates for the brands they enjoy by paying them cash for approved posts. “Surpassing 10,000 paid posts is a significant achievement for the Thumzup platform and we believe...

Mike BruceChief Executive Officer of Brown & Brown EuropeDAYTONA BEACH, Fla., Sept. 07, 2023 (GLOBE NEWSWIRE) — Brown & Brown, Inc. (NYSE: BRO) has announced the promotion of Mike Bruce to chief executive officer of Brown & Brown Europe. Mike was formerly the chief executive officer of Global Risk Partners (GRP), which was acquired by Brown & Brown in July 2022. In his new role, Mike will lead Brown & Brown’s overall European strategy. Commenting on the business rationale, Mike said his goal is to enable the European teams to build more connectivity and leverage the financial strength and scale of Brown & Brown with insurers, customers and potential acquisitions. Mike says, ”Our teammates will be able to derive value from our combined capabilities and deeper collaboration. ‘The Power of...

• Update on Phase 2a data for JNJ-0953 (CD388) for universal prevention of seasonal influenza from Janssen Pharmaceuticals, Inc. leadership following Election to Proceed notification • Detailed overview of potential role of Drug-Fc Conjugates (DFCs) in oncology; Cidara to present clinical development strategy for DFCs, focusing on CD73, chemokine receptors, and multispecific DFCs targeting solid tumors • Formal Q&A session with KOL’s to follow presentations SAN DIEGO, Sept. 07, 2023 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, today announced it will host a virtual R&D Day on Thursday, September...

MIAMI, Sept. 07, 2023 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN NASDAQ: LGVNR) (“Longeveron” or “Company”), a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (HLHS), Alzheimer’s disease and Aging-related Frailty, announced today an abstract highlighting long-term survival data from the Company’s ELPIS 1 trial of Lomecel-B™ for patients with hypoplastic left heart syndrome (HLHS) has been accepted for presentation as a poster at the upcoming meeting of the American Heart Association (AHA). The poster, titled Long-term Transplant-free Survival Is Improved in Hypoplastic Left Heart Syndrome with Cell-based Therapy (Sunjay Kaushal, et al.), will be presented at the Scientific Sessions of the American Heart...

Includes a state-of-the-art broadcast studio, dedicated IPO and Market Intelligence Centers, and a gallery space celebrating Nasdaq-listed companies CNBC’s “Fast Money” will broadcast its show from the new studio each weeknight at 5pm ET at MarketSite Coincides with the launch of Nasdaq’s new brand campaignNEW YORK, Sept. 07, 2023 (GLOBE NEWSWIRE) — Nasdaq (Nasdaq: NDAQ) today announced the reopening of the second floor of its iconic MarketSite at 151 W. 42nd Street in Times Square. The new space includes a state-of-the-art broadcast and production studio that will be home to CNBC’s “Fast Money,” a dedicated IPO Center for first trade celebrations, and a new gallery space commemorating the historic moments and innovation of our listed companies, many of which are Nasdaq-100® companies. “Since its inception, the Nasdaq MarketSite...

Funds will advance research into ELI-007, a mutant BRAF-peptide vaccine, and ELI-008, a p53 hotspot mutation-peptide vaccine, with the aim of developing multivalent cancer vaccines targeting several mutationsThis $2.6 million grant is an addition to the $2.8 million that GIRF awarded Elicio in September 2022BOSTON, Sept. 07, 2023 (GLOBE NEWSWIRE) — Elicio Therapeutics, Inc. (NASDAQ: ELTX, “Elicio Therapeutics” or “Elicio”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer, today announced that it has been awarded a $2.6 million grant from the GI Research Foundation in Chicago to fund research for two therapeutic cancer vaccines, ELI-007 and ELI-008. This $2.6 million grant is an addition to the $2.8 million that it awarded Elicio in September 2022. Funds will...

First patient has been enrolled in the Dose Confirmation stage (n=18) of the Phase 2 SPECTRA clinical trial for intravitreal 4D-150 in patients with diabetic macular edemaFirst patient enrolled in Population Extension cohort of Phase 2 stage of PRISM clinical trial in wet AMD (n=up to 45) to evaluate intravitreal 4D-150 in patients with lower anti-VEGF need compared with initial cohortsAll PRISM patient cohorts to inform pivotal clinical trial design for 4D-150; FDA feedback on Phase 3 design expected in Q4 2023 with update expected in Q1 2024Initial interim data for SPECTRA Dose Confirmation and PRISM Population Extension cohort expected in 2024; guidance for randomized Phase 2 stage (n=50) in highest anti-VEGF need patients on-track for H1 2024EMERYVILLE, Calif., Sept. 07, 2023 (GLOBE NEWSWIRE) — 4D Molecular Therapeutics (Nasdaq:...

Mineral Resource EstimateMineral Resource EstimateTORONTO, Sept. 07, 2023 (GLOBE NEWSWIRE) — Copper Lake Resources Ltd. (TSX-V: CPL, Frankfurt: WOI, OTC: WTCZF) (“Copper Lake” or the “Company”) is pleased to announce an updated Mineral Resource Estimate (“MRE”) prepared in accordance with National Instrument 43-101, Standard for Disclosure for Mineral Projects (“NI 43-101”) for its Norton Lake nickel-copper-cobalt-platinum group element deposit (the “Deposit”), situated 50 km northeast of Fort Hope and approximately 413 km northeast of Thunder Bay in northern Ontario. Highlights Include:Open pit and underground Measured and Indicated Resources of 1,957,368 tonnes at an average grade of 0.67% Ni, 0.66% Cu, 321 ppm Co, 0.49 g/t Pt, 0.17 g/t Pd (1.07% NiEq) and containing 29.1Mlbs of nickel and 28.3Mlbs of copper. Open...